ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Sun Pharmaceutical has received shareholder approval to reclassify specific persons from the 'Promoter Group' to the 'Public' category, in compliance with SEBI Listing Regulations.
Sun Pharmaceutical Industries Ltd received no-objection letters from the NSE and BSE to reclassify certain members from the promoter group to the public category.
Sun Pharmaceutical applied for reclassifying certain 'Promoter Group' shareholders into the 'Public' category. The regulatory move follows earlier internal company board intimations from May 2026.
Sun Pharma received requests from three promoter group members to reclassify 4,31,75,371 shares to the public category. The board will examine these requests in due course.